Skip to content
First aid cross icon

19/07/2024 – Please be reassured, our Sciensus systems are unaffected by the global Microsoft outage. All patient medicine deliveries will go ahead as scheduled.

Sciensus continues to extend the full range of its services across Europe

Sciensus, a life sciences business, specialising in patient access, engagement and insight solutions has announced that it is extending the full range of its services to Switzerland.

The Swiss office, located in Zug and led by Managing Director, Tina Lupberger, will bolster Sciensus’ European offering by adding patient insights to the well-established support network for patients with long-term conditions, rare diseases, and cancer, to give them more control of their medicine and help them achieve the best health outcomes.

Sciensus has a significant EU footprint, with offices in the Netherlands, Germany, and Switzerland, which are all now part of the drive to extend their digitally-enabled patient insights offering internationally.

Tens of millions of patient interactions every year, captured through advanced patient apps and digital platforms, allow Sciensus to gather vital insight into patient experience and the drivers of medicine adherence. Powered by these interactions, Sciensus develops and deploys innovative patient interventions and support programmes, which generate invaluable real-world insight to enable clinicians and pharmaceutical companies to drive an elevated patient experience and better health  outcomes for patients.

Tina Lupberger, Managing Director of Sciensus Switzerland, said: “I look forward to working with our global team to drive and deliver digitally-enabled solutions, and providing access to innovative medicines for our patients in Switzerland and beyond. Leveraging my experience of 30 years in the pharmaceutical industry, I am excited to build a world class team who will help us achieve our vision to help each and every patient make the most out of their medicine.”

Darryn Gibson, CEO of Sciensus, said: “Tina’s experience from leading roles in renowned pharmaceutical companies, both in Switzerland and internationally, will be invaluable in helping us advance our patient outreach and engagement programmes. We look forward to working together to uncover profound insights about how patients interact with medicines in a real-world setting, enabling pharmaceutical companies and healthcare professionals to make faster, more informed decisions.”